15-Deoxy-Δ12,14-prostaglandin J2 induces p53 expression through Nrf2-mediated upregulation of heme oxygenase-1 in human breast cancer cells

Free Radical Research

Volumn 48, Issue 9, 2014, Pages 1018-1027

  Kim, D H ^a   Song, N Y ^a   Kim, E H ^a   Na, H K ^b   Joe, Y ^c   Chung, H T ^c   Surh, Y J ^a  

^a Seoul National University   (South Korea)

^b Sungshin Women's University   (South Korea)

^c University of Ulsan   (South Korea)

Author keywords

Cyclopentenone prostaglandin; H ferritin; Heme oxygenase 1; P53

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; DEFEROXAMINE; FERRITIN; FERROUS ION; HEME OXYGENASE 1; IRON; PHENANTHROLINE; PROTEIN P21; PROTEIN P53; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; 15-DEOXYPROSTAGLANDIN J2; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; NFE2L2 PROTEIN, HUMAN; PROSTAGLANDIN D2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; BREAST CANCER; CANCER RESISTANCE; CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MCF 7 CELL LINE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BREAST TUMOR; KNOCKOUT MOUSE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HEME OXYGENASE-1; HUMANS; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; PROSTAGLANDIN D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84906053071     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2014.897343     Document Type: Conference Paper

References (57)

1. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD Science 2004 304 596-600
2. Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I, et al. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 2004 64 2350-2356
3. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389: 300-305
4. Tan M, Li S, Swaroop M, Guan K, Oberley LW, Sun Y. Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 1999 274 12061-12066
5. Yoon KA, Nakamura Y, Arakawa H. Identifi cation of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet 2004 49 134-140
6. Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA. Infl uence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol 2003 23 8576-8585
7. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. The antioxidant function of the p53 tumor suppressor. Nat Med 2005 11 1306-1313
8. Meiller A, Alvarez S, Drane P, Lallemand C, Blanchard B, Tovey M, May E. p53-dependent stimulation of redox-related genes in the lymphoid organs of gamma-irradiated-mice identifi cation of Haeme-oxygenase 1 as a direct p53 target gene. Nucleic Acids Res 2007 35 6924-6934
9. Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci U S A 1996 93 11848-11852
10. Lotem J, Peled-Kamar M, Groner Y, Sachs L. Cellular oxidative stress and the control of apoptosis by wild-Type p53, cytotoxic compounds, and cytokines. Proc Natl Acad Sci U S A 1996 93 9166-9171
11. Otterbein LE, Choi AM. Heme oxygenase: Colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000 279 L1029-1037
12. Maines MD. The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997 37 517-554
13. Kim YM, Choi BM, Kim YS, Kwon YG, Kibbe MR, Billiar TR, Tzeng E. Protective eff ect of p53 in vascular smooth muscle cells against nitric oxide-induced apoptosis is mediated by up-regulation of heme oxygenase-2. BMB Rep 2008 41 164-169
14. Liu XM, Chapman GB, Wang H, Durante W. Adeno virusmediated heme oxygenase-1 gene expression stimulates apoptosis in vascular smooth muscle cells. Circulation 2002 105 79-84
15. Lee SY, Jo HJ, Kim KM, Song JD, Chung HT, Park YC. Concurrent expression of heme oxygenase-1 and p53 in human retinal pigment epithelial cell line. Biochem Biophys Res Commun 2008 365 870-874
16. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B. Identifi cation and classifi cation of p53-regulated genes. Proc Natl Acad Sci U S A 1999 96 14517-14522
17. Fang J, Akaike T, Maeda H. Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment. Apoptosis 2004; 9: 27-35
18. Jozkowicz A, Was H, Dulak J. Heme oxygenase-1 in tumors: Is it a false friend?. Antioxid Redox Signal 2007 9 2099-2117
19. Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi MC, Holbrook NJ. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 1997; 14: 929-935
20. Inguaggiato P, Gonzalez-Michaca L, Croatt AJ, Haggard JJ, Alam J, Nath KA. Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int 2001; 60: 2181-2191
21. Kim EH, Surh YJ. 15-Deoxy- δ 12,14 -prostaglandin J 2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem Pharmacol 2006 72 1516-1528
22. Na HK, Surh YJ. Peroxisome proliferator-Activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation. Biochem Pharmacol 2003 66 1381-1391
23. Kim DH, Kim EH, Na HK, Surh YJ. Eff ects of 15-deoxy-δ 12,14 -prostaglandin J 2 on the expression of p53 in MCF-7 cells. Ann N Y Acad Sci 2009 1171 202-209
24. Kim DH, Kim JH, Kim EH, Na HK, Cha YN, Chung JH, Surh YJ. 15-Deoxy- δ 12,14 -prostaglandin J 2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: Possible roles of iron and ROS. Carcinogenesis 2009 30 645-654
25. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 1999 103 R23-R29
26. Miralem T, Hu Z, Torno MD, Lelli KM, Maines MD. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. J Biol Chem 2005 280 17084-17092
27. Du T, Ciccotosto GD, Cranston GA, Kocak G, Masters CL, Crouch PJ, et al. Neurotoxicity from glutathione depletion is mediated by Cu-dependent p53 activation. Free Radic Biol Med 2008 44 44-55
28. Lin F, Girotti AW. Hemin-enhanced resistance of human leukemia cells to oxidative killing: Antisense determination of ferritin involvement. Arch Biochem Biophys 1998 352 51-58
29. Zhang F, Wang W, Tsuji Y, Torti SV, Torti FM. Posttranscriptional modulation of iron homeostasis during p53-dependent growth arrest. J Biol Chem 2008; 283: 33911-33918
30. Kim EH, Na HK, Kim DH, Park SA, Kim HN, Song NY, Surh YJ. 15-Deoxy- δ 12,14 -prostaglandin J 2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: A potential role of ROS. Carcinogenesis 2008 29 688-695
31. Dinkova-Kostova AT, Holtzclaw WD, Wakabayashi N. Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein. Biochemistry 2005 44 6889-6899
32. Hao Q, Maret W. Aldehydes release zinc from proteins. A pathway from oxidative stress/lipid peroxidation to cellular functions of zinc. FEBS J 2006 273 4300-4310
33. Fitzpatrick FA, Wynalda MA. Albumin-catalyzed metabolism of prostaglandin D 2. Identifi cation of products formed in vitro. J Biol Chem 1983 258 11713-11718
34. Jowsey IR, Thomson AM, Flanagan JU, Murdock PR, Moore GB, Meyer DJ, et al. Mammalian class Sigma glutathione S-Transferases: Catalytic properties and tissue-specifi c expression of human and rat GSH-dependent prostaglandin D2 synthases. Biochem J 2001 359 507-516
35. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have anti-infl ammatory properties. Nat Med 1999; 5: 698-701
36. Shibata T, Kondo M, Osawa T, Shibata N, Kobayashi M, Uchida K. 15-Deoxy- δ 12,14 -prostaglandin J 2. A prostaglandin D 2 metabolite generated during infl ammatory processes. J Biol Chem 2002 277 10459-10466
37. Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, et al. Ligands of the peroxisome proliferator-Activated receptors (PPAR βand PPAR β) reduce myocardial infarct size. FASEB J 2002; 16: 1027-1040
38. Deramaudt BM, Braunstein S, Remy P, Abraham NG. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 1998 68 121-127
39. Liu ZM, Chen GG, Ng EK, Leung WK, Sung JJ, Chung SC. Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene 2004 23 503-513
40. Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, Yamauchi J, et al. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 2003 6 15-24
41. Halliwell B. Oxidative stress and cancer: Have we moved forward?. Biochem J 2007; 401: 1-11
42. Bensaad K, Vousden KH. Savior and slayer: The two faces of p53. Nat Med 2005 11 1278-1279
43. Ladelfa MF, Toledo MF, Laiseca JE, Monte M. Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production. Antioxid Redox Signal 2011 15 1749-1761
44. Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005 10 1881-1896
45. Nam SY, Sabapathy K. p53 promotes cellular survival in a context-dependent manner by directly inducing the expression of haeme-oxygenase-1. Oncogene 2011 30 4476-4486
46. You A, Nam CW, Wakabayashi N, Yamamoto M, Kensler TW, Kwak MK. Transcription factor Nrf2 maintains the basal expression of Mdm2: An implication of the regulation of p53 signaling by Nrf2. Arch Biochem Biophys 2011 507 356-364
47. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol Rev 2006 86 583-650
48. Suttner DM, Dennery PA. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J 1999 13 1800-1809
49. Weng YH, Tatarov A, Bartos BP, Contag CH, Dennery PA. HO-1 expression in type II pneumocytes after transpulmonary gene delivery. Am J Physiol Lung Cell Mol Physiol 2000 278 L1273-L1279
50. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 1992; 12: 417-427
51. Cairo G, Tacchini L, Pogliaghi G, Anzon E, Tomasi A, Bernelli-Zazzera A. Induction of ferritin synthesis by oxidative stress. Transcriptional and post-Transcriptional regulation by expansion of the "free" iron pool. J Biol Chem 1995 270 700-703
52. Elliott RL, Elliott MC, Wang F, Head JF. Breast carcinoma and the role of iron metabolism. A cytochemical, tissue culture, and ultrastructural study. Ann N Y Acad Sci 1993 698 159-166
53. Guner G, Kirkali G, Yenisey C, Tore IR. Cytosol and serum ferritin in breast carcinoma. Cancer Lett 1992; 67: 103-112
54. Arosio P, Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med 2002; 33: 457-463
55. Song NY, Kim DH, Kim EH, Na HK, Kim NJ, Suh YG, Surh YJ. Multidrug resistance-Associated protein 1 mediates 15-deoxy- δ 12,14 -prostaglandin J 2 -induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells. Chem Res Toxicol 2011 24 1231-1241
56. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995 358 1-3
57. Chen W, Sun Z, Wang XJ, Jiang T, Huang Z, Fang D, Zhang DD. Direct interaction between Nrf2 and p21(Cip1/ WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell 2009 34 663-673.